SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-298545
Filing Date
2022-12-05
Accepted
2022-12-05 17:20:59
Documents
2
Group Members
KATHERINE H. HALPERN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d770056dsc13ga.htm SC 13G/A 61529
2 EX-A d770056dex99a.htm EX-99.A 3240
  Complete submission text file 0001193125-22-298545.txt   66275
Mailing Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121
Business Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42217 | Film No.: 221445868
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
HALPERN JOHN D (Filed by) CIK: 0001234950 (see all company filings)

Type: SC 13G/A